Francesco Emma
Papers
1
Total Citations
42
H-Index
1
About
Francesco Emma is a leading pediatric nephrologist whose research has fundamentally advanced the understanding and treatment of rare kidney diseases, particularly nephrotic syndrome and congenital anomalies of the kidney and urinary tract (CAKUT). His work bridges the critical gap between molecular mechanisms and clinical care, with a special focus on developing innovative therapies for conditions that affect only a small number of patients but represent a significant medical burden. Among his most impactful contributions is a pioneering study on high-content drug screening for rare diseases (42 citations), which demonstrated a novel, scalable approach to identifying potential treatments for underserved patient populations—a methodology that has since inspired similar efforts across the rare disease community. Emma’s research is widely cited, reflecting his role in shaping both clinical guidelines and translational research. He has also been instrumental in establishing international registries and clinical trials for rare pediatric kidney disorders, ensuring that evidence-based treatments reach the patients who need them most. Through his work, Francesco Emma has become a vital voice for the rare disease community, proving that even the smallest patient populations deserve—and can benefit from—rigorous scientific investigation.
Research Focus
Key Achievements
Top Papers
- 1High‐content drug screening for rare diseases42 citations · 2017